Status: current, Primitive. Date: 31-Mar 2022. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4678161000168117 | sacituzumab govitecan (AU substance) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4678171000168111 | sacituzumab govitecan | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| sacituzumab govitecan | Is a | medicinal substance | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Trodelvy 180 mg powder for injection, 180 mg vial | has intended active ingredient | True | sacituzumab govitecan | Inferred relationship | Some | 288093209 |
| Trodelvy 180 mg powder for injection, 180 mg vial | has Australian BoSS | True | sacituzumab govitecan | Inferred relationship | Some | 288093209 |
| sacituzumab govitecan | has intended active ingredient | True | sacituzumab govitecan | Inferred relationship | Some | 134429679 |
| sacituzumab govitecan 180 mg injection, vial | has intended active ingredient | True | sacituzumab govitecan | Inferred relationship | Some | 606802513 |
| sacituzumab govitecan 180 mg injection, vial | has Australian BoSS | True | sacituzumab govitecan | Inferred relationship | Some | 606802513 |
This concept is not in any reference sets
FHIR